GRI - GRI Bio, Inc.
2.4
0 0%
Share volume: 19,212
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$2.40
0.00
0.00%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 03-14-2025 | 05-15-2025 | 11-14-2025 | 01-30-2026 | |
| Cash flow financing | 2.281 M | -11.000 K | 1.246 M | 7.148 M | |
| Other financing cash flows | 761.000 K | -1.000 K | 1.000 K | -1.000 K | |
| Cash flow | 0.000 | -1.747 M | 0.000 | 4.174 M | |
| Net income | -1.947 M | -3.046 M | -3.359 M | -2.659 M | |
| Depreciation | 1.000 K | 1.000 K | 1.000 K | 1.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | -3.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 282.000 K | -1.747 M | -1.067 M | 4.174 M |